Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

Genzyme backs first International Pompe Day

Raises awareness of rare neuromuscular disease

- PMLiVE

Integrating multichannel marketing

External forces are driving the need for pharma to use a greater variety of channels to reach customers

- PMLiVE

Tuberculosis: treatment and prevention

One of the most significant global diseases, effective new TB therapies are sorely needed

National Institute for Health and Care Excellence NICE logo

NICE gives partial backing to Ferring’s prostate cancer drug

Firmagon on course for use on NHS in England and Wales

- PMLiVE

BioAlliance and Topotarget merge to focus on rare cancers

French and Danish firms combine to develop orphan oncology drugs

- PMLiVE

Menarini launches urology campaign in Greece

PE information push includes Not Just A Moment website

- PMLiVE

Sanofi takes to Twitter to support Spanish pharmacy portal

Says new account on the social network will help support community pharmacists

- PMLiVE

GSK gets OK in US for diabetes drug albiglutide

Once-weekly Tanzeum will compete against Victoza and Byetta after FDA approval

- PMLiVE

Boehringer plans to open trial data back to 1998

Will partner with Sanofi, GSK, Roche, Novartis and ViiV Healthcare on online platform

- PMLiVE

Merck gets US green light for allergy immunotherapy

Expected to provide a significant boost to company's partner Alk-Abello

Bristol-Myers Squibb (BMS) building

BMS files fixed-dose HIV combination in US

Combines Reyataz with Gilead Sciences' cobicistat

European Commission launches mHealth consultation

May lead to policy action by 2015

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links